Results per Page:
Dysregulated purine metabolism produces profound neurodevelopmental defects
From the Kollman and Wills Labs, University of Washington Biochemistry Department
MGRN1 and ATRN cooperate to regulate melanocortin signaling
From the Kong Lab, University of Washington Biochemistry Department
Guiding the attack: CXCR3 leads CAR T cells to pediatric brain tumors
From the Vitanza Lab, Seattle Children’s Research Institute, University of Washington and the Cancer Consortium
From Data to Diagnosis: GREGoR aims to demystify rare diseases
From the Genomics Research to Elucidate the Genetics of Rare Diseases (GREGoR) Consortium, including the Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium
Reducing inequities in cancer care through shared identities
From the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium
X-scape artistry: CTCF insulates X-linked genes from silencing
From the Disteche Lab, University of Washington Department of Laboratory Medicine & Pathology and the Cancer Consortium program in Cancer Basic Biology
Surprising chromatin biology at the (centromeric) core of who we are
From Stergachis lab, University of Washington, and Dr. Sue Biggins, Fred Hutch Basic Sciences Division
Donor factors influence success of fecal microbiota transplant
From the Rashidi Group, Pathogen Associated Malignancies Program of the Cancer Consortium and Clinical Research Division
Towards accessible gene therapy: in vivo base editing to cure Sickle Cell Disease
From the Cancer Consortium Lieber Lab, Department of Laboratory Medicine and Pathology, University of Washington
From humans, to mice, to plants: sometimes a little poison is a good thing
From The Bradley Lab, Public Health Sciences and Basic Sciences Divisions.
Understanding how microbial imbalances may influence Juvenile Dermatomyositis, a rare immune-mediated disease
From the Dey Lab, Pathogen Associated Malignancies Program of the Cancer Consortium
Menopausal hormone therapy may lower the risk of colorectal cancer
From the Peters and Hsu Groups, Cancer Consortium & Public Health Sciences Division
El momento en que se administra la TAR para el VIH es más importante de lo que imaginábamos
De los grupos de los doctores Edlefsen y Frenkel, Consorcio Oncológico
Timing of ART administration for HIV is more important than we thought
From the Edlefsen and Frenkel Groups, Cancer Consortium
10 Washington groups take on cancer health disparities with grants from Fred Hutch
Community Grants Program funds projects statewide to improve cancer outcomes and build organizational capacity
Neuron-glia love triangles at single-cell resolution
From the Singhvi Lab, Basic Sciences Division
Mechanical coupling helps microtubules coordinate chromosomal separation
From the Asbury lab, University of Washington and Biggins lab, Fred Hutch Basic Sciences Division, Cancer Consortium Cancer Basic Biology Program
A coordinated care approach rapidly gets COVID-19 therapy into the hands of high-risk cancer patients
From Drs. Eduardo Sanchez, Steven Pergam, and Catherine Liu, ,Fred Hutch Vaccine and Infectious Diseases Division and Cancer Consortium Hematologic Program
Using mathematical models to tell time of initial HIV infection in infants
From the Overbaugh/Lehman Lab, Cancer Consortium and Human Biology Division
From predicted neoantigen to T cell therapy for acute myeloid leukemia
From the Bleakley Lab, Cancer Consortium and Translational Science & Therapeutics Division